Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma

Med Pediatr Oncol. 2001 Jan;36(1):24-7. doi: 10.1002/1096-911X(20010101)36:1<24::AID-MPO1007>3.0.CO;2-7.

Abstract

Background: Neuroblastoma tumorigenesis may involve the differential inactivation of multiple tumor suppressor genes. Recent data have suggested that a neuroblastoma suppressor gene may be located on the long arm of chromosome 11 (11q).

Procedure: We therefore analyzed 295 primary neuroblastomas from a representative group of patients for loss of heterozygosity (LOH) at 25 polymorphic markers spanning 11q.

Results: LOH was observed in 129 primary neuroblastomas (44%), and a common region of LOH mapped to 11q14-23. No correlation was found between 11q LOH and adverse prognostic variables, but a strong inverse relationship between 11q LOH and MYCN amplification (P < 0.001) was observed. There was no difference in overall survival when patients were stratified by 11q LOH status. However, 11q LOH was associated with a decreased overall survival probability when patients whose tumors had a single copy of MYCN were analyzed separately (P = 0.008).

Conclusion: These data support the hypothesis that a tumor suppressor gene mapping within 11q14-23 is frequently inactivated during the malignant evolution of neuroblastoma.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles*
  • Child
  • Child, Preschool
  • Chromosome Mapping
  • Chromosomes, Human, Pair 1 / genetics
  • Chromosomes, Human, Pair 11 / genetics*
  • Chromosomes, Human, Pair 11 / ultrastructure
  • Female
  • Gene Deletion*
  • Genes, myc
  • Genotype
  • Humans
  • Infant
  • Life Tables
  • Loss of Heterozygosity*
  • Male
  • Neuroblastoma / genetics*
  • Neuroblastoma / mortality
  • Polymerase Chain Reaction
  • Prognosis
  • Proportional Hazards Models
  • Survival Analysis